The role of cyclooxygenase and lipoxygenase in cancer chemoprevention (Q34153217)

31 July 2017

1 reference

title

The role of cyclooxygenase and lipoxygenase in cancer chemoprevention (English)

1 reference

31 July 2017

Cuendet M

1

1 reference

31 July 2017

Pezzuto JM

series ordinal

2

1 reference

31 July 2017

publication date

1 January 2000

1 reference

Drug Metabolism and Drug Interactions

31 July 2017

published in

1 reference

31 July 2017

volume

17

1 reference

31 July 2017

issue

1-4

1 reference

31 July 2017

page(s)

109-157

1 reference

Prostaglandins and cancer: an update

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Review: Prostaglandins and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Prostaglandin synthase-mediated metabolism of carcinogens and a potential role for peroxyl radicals as reactive intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Effects of eicosanoid synthesis inhibitors on the in vitro growth and prostaglandin E and leukotriene B secretion of a human breast cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Prostaglandins, their inhibitors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Inhibition of tumour growth by lipoxygenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Recent Advances in Chemoprevention of Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Interactions of PGH synthase isozymes-1 and -2 with NSAIDs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Discovery of a second 15S-lipoxygenase in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

21 January 2018

Cancer statistics, 1998

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Prostaglandin H synthase and xenobiotic oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Self-promotion? Intimate connections between APC and prostaglandin H synthase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Inhibition of lung tumourigenesis by sulindac: comparison of two experimental protocols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Apoptosis and APC in colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Expression of 15-lipoxygenase by human colorectal carcinoma Caco-2 cells during apoptosis and cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Immunocytochemical localization of arachidonate 15-lipoxygenase in erythrocytes, leukocytes, and airway cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

21 January 2018

Cancer statistics, 1990.

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Cyclooxygenase-2 expression in human pancreatic adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

A comparison of the effects of the prostaglandin synthesis inhibitors indomethacin and carprofen on 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats fed different amounts of essential fatty acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Prostaglandins and cancer: A review of tumor initiation through tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Prostaglandins and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Nonsteroidal antiinflammatory drugs and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Characterization of a 15-lipoxygenase in human breast carcinoma BT-20 cells: stimulation of 13-HODE formation by TGF alpha/EGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

21 January 2018

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

An overview of skin cancers. Incidence and causation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Arachidonic acid metabolites in cutaneous carcinomas. Evidence suggesting that elevated levels of prostaglandins in basal cell carcinomas are associated with an aggressive growth pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Prostaglandin-H-synthase isozyme expression in normal and neoplastic human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Localization of prostaglandin H synthase isoenzymes in murine epidermal tumors: suppression of skin tumor promotion by inhibition of prostaglandin H synthase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Eicosanoids and multistage carcinogenesis in NMRI mouse skin: role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

12-Lipoxygenase isoenzymes in mouse skin tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Constitutive expression of 8-lipoxygenase in papillomas and clastogenic effects of lipoxygenase-derived arachidonic acid metabolites in keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Cytogenetic effects caused by phorbol ester tumor promoters in primary mouse keratinocyte cultures: correlation with the convertogenic activity of TPA in multistage skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Cyclooxygenase and lipoxygenase inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Sunlight and the onset of skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

21 January 2018

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Chemoprevention of OH-BBN-induced bladder cancer in mice by piroxicam

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Hepatocellular carcinoma: Recent progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

The morphologic transition in hepatocellular carcinoma. A comparison of the individual histologic features disclosed by ultrasound-guided fine-needle biopsy with those of autopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Aspirin induced apoptosis in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Nonsteroidal anti-inflammatory drugs and colorectal cancer: Evolving concepts of their chemopreventive actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Nonsteroidal antiinflammatory drugs and colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy M

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Inhibition of lung tumorigenesis by NSAIDS: a working hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Pharmacology of Curcuma longa

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Antioxidant activity of curcumin and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Progress in cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Risk factors for gallbladder cancer: a Polish case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Cancer Mortality in Relation to National Consumption of Cigarettes, Solid Fuel, Tea and Coffee

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Tea and tea polyphenols inhibit cell hyperproliferation, lung tumorigenesis, and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Protection against polycyclic aromatic hydrocarbon-induced skin tumor initiation in mice by green tea polyphenols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Inhibition of 12-O-Tetradecanoylphorbol-13-Acetate and Other Skin Tumor-Promoter-Caused Induction of Epidermal Interleukin-1α mRNA and Protein Expression in SENCAR Mice by Green Tea Polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Protection against ultraviolet B radiation-induced effects in the skin of SKH-1 hairless mice by a polyphenolic fraction isolated from green tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Structure-antioxidant activity relationships of flavonoids and phenolic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Activation of mitogen-activated protein kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Inhibition of carcinogenesis by tea: bioavailability of tea polyphenols and mechanisms of actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Modulation of the UVA activation of haem oxygenase, collagenase and cyclooxygenase gene expression by epigallocatechin in human skin cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Protection against microcystin-LR-induced hepatotoxicity by Silymarin: biochemistry, histopathology, and lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Inhibitory effect of silymarin, an anti-hepatotoxic flavonoid, on 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity and mRNA in SENCAR mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Inhibitory effects of phytopolyphenols on TPA‐induced transformation, PKC activation, andc‐junexpression in mouse fibroblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Antitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Difference in transcriptional regulatory function between c-Fos and Fra-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Inhibitory effects of caffeic acid phenethyl ester (CAPE) on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in mouse skin and the synthesis of DNA, RNA and protein in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Enhanced endothelial cell retraction mediated by 12(S)-HETE: a proposed mechanism for the role of platelets in tumor cell metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

21 January 2018

Towards a better aspirin

1 reference

https://api.crossref.org/works/10.1515/DMDI.2000.17.1-4.109

Antitumor promoting activity of (−)-epigallocatechin gallate, the main constituent of “Tannin” in green tea

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/PTR.2650010110

Natural antioxidants. III. Antioxidative components isolated from rhizome of Curcuma longa L

10 April 2024

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.33.1725

Identifiers

DOI

10.1515/DMDI.2000.17.1-4.109

1 reference

31 July 2017

1 reference